Supplementary Figure S5 from Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy
Abstract
Monitoring ctDNA to assess alpelisib-mediated reversal of pyrotinib resistance in her2-positive breast cancer
Fields of Study & Subjects
Advanced Breast Cancer Therapies
Lung Cancer Treatments and Mutations
Cancer
Lipids
and Metabolism
Publication details
- Publication date
- 2 January 2026